medtech – Soliton Solutions PR https://www.solitonsolutions.com Public Relations Tue, 21 Oct 2025 15:55:12 +0000 en-GB hourly 1 https://www.solitonsolutions.com/wp-content/uploads/2018/10/cropped-soliton-tshirt-32x32.png medtech – Soliton Solutions PR https://www.solitonsolutions.com 32 32 Press Release: Staymed Mixer Allows For On Demand Creation of A-Concentrate From Powder Tailored For Patients Needs https://www.solitonsolutions.com/2022/04/26/press-release-staymed-mixer-allows-for-on-demand-creation-of-a-concentrate-from-powder-tailored-for-patients-needs/ Tue, 26 Apr 2022 13:21:44 +0000 https://www.solitonsolutions.com/?p=3644 Soliton solutions PR - Tech trade show exhibition specialists

staymedThe industry standard for dialysis using B-concentrate is to deliver it by powder and create the dialysis fluid on-demand at hospitals. Unfortunately that isn’t the case with A-Concentrate. Which means huge shipping costs and troublesome handling.Staymed has come up with a revolutionary mixer that solves this problem. It accomplishes this by using a special membrane […]

The post Press Release: Staymed Mixer Allows For On Demand Creation of A-Concentrate From Powder Tailored For Patients Needs appeared first on Soliton Solutions PR.

]]> Soliton solutions PR - Tech trade show exhibition specialists

staymed
staymed

The industry standard for dialysis using B-concentrate is to deliver it by powder and create the dialysis fluid on-demand at hospitals. Unfortunately that isn’t the case with A-Concentrate. Which means huge shipping costs and troublesome handling.

Staymed has come up with a revolutionary mixer that solves this problem. It accomplishes this by using a special membrane to separate and eventually mix RO-water and powder containing the necessary ingredients needed for A-Concentrate..

So what does this mean? It means there’s no longer a need to transport heavy containers of pre-mixed A-Concentrate with an expiration date. Making it easier for medical personnel to perform dialysis on demand. Nurses will no longer have to carry heavy containers of A-Concentrate, doctors can tailor the fluid as they see fit right before treatment, and of course storage space and storage requirements such as temperature are reduced an incredible amount.

But more importantly with the Staymed system the carbon footprint of dialysis would be reduced up to 70%. With only the need to transport the powder bags the total weight of shipments will be reduced substantially. In addition to this hospitals no longer need to worry about expiration dates of the A-concentrate because the powders have an almost infinite shelf-life.

Another aspect of this is that the Staymed solution can be used in hard to reach areas where it was previously very difficult to transport A-concentrate to.

The potential market size for this is 1.170 Mio € globally – based on 390 Mio treatments pa. The market potential only in Europe is 470 Mio €. Currently Staymed is looking for partners and investors to help bring this life saving solution to market as soon as possible.

Staymed holds a patent for their solution and has also built a working prototype which you can see demoed in the below video.

 

 

###

Staymed AB is a med-tech startup based in Sweden and founded by inventor Per-Olov Carlsson in cooperation with patent attorneys Erik Krahbichler and Pär Hjalmarsson. They hope to revolutionize the dialysis market with A-Concentrate the same way that has been done with B-Concentrate..

https://staymed.se/

The post Press Release: Staymed Mixer Allows For On Demand Creation of A-Concentrate From Powder Tailored For Patients Needs appeared first on Soliton Solutions PR.

]]> Press Release: Patent Agency Kipa Shifts Focus Back to Medical Devices to Do Their Part in the COVID-19 Crisis https://www.solitonsolutions.com/2020/05/18/press-release-patent-agency-kipa-shifts-focus-back-to-medical-devices-to-do-their-part-in-the-covid-19-crisis/ https://www.solitonsolutions.com/2020/05/18/press-release-patent-agency-kipa-shifts-focus-back-to-medical-devices-to-do-their-part-in-the-covid-19-crisis/#respond Mon, 18 May 2020 07:59:53 +0000 https://www.solitonsolutions.com/?p=3358 Soliton solutions PR - Tech trade show exhibition specialists

Patent Agency Kipa Shifts Focus Back to Medical Devices to Do Their Part in the COVID-19 Crisis2020-05-18 Helsingborg, Sweden:KIPA (Krahbichler Intellectual Property Advisors) has earned a reputation as one of the best IP firms for providing highly specialized professional advice to the medical device industry. Now KIPA provides quality IP services for diverse clients involved with innovations in several technological fields.With the ongoing Covid-19 situation there has been an increased interest […]

The post Press Release: Patent Agency Kipa Shifts Focus Back to Medical Devices to Do Their Part in the COVID-19 Crisis appeared first on Soliton Solutions PR.

]]> Soliton solutions PR - Tech trade show exhibition specialists

Patent Agency Kipa Shifts Focus Back to Medical Devices to Do Their Part in the COVID-19 Crisis
Patent Agency Kipa Shifts Focus Back to Medical Devices to Do Their Part in the COVID-19 Crisis

2020-05-18 Helsingborg, Sweden:

KIPA (Krahbichler Intellectual Property Advisors) has earned a reputation as one of the best IP firms for providing highly specialized professional advice to the medical device industry. Now KIPA provides quality IP services for diverse clients involved with innovations in several technological fields.

With the ongoing Covid-19 situation there has been an increased interest in developing medical technologies.

 

In order to aid this commendable effort KIPA is going back to its roots and is inviting any developers of medical devices or technologies to come to KIPA for help with securing the intellectual property side of this new push.

The world has handled this pandemic fairly well. One thing that is certain is that when the next global medical event takes place the world will be more ready than ever.

 

With 13 years of experience with aiding the medical device industries IP needs you can be sure that KIPA is up to the challenge. KIPA handles cases for clients ranging from startups to major industries and universities. 

Should you have any questions or concerns regarding the development of new medical technologies KIPA will have the answer. A great start for any new technology is a freedom to operate analysis to ensure that your technology will reach the market without unnecessary delays.

“We look forward to assist our existing and future clients in these challenging times. Strong IP protection has proven to support and strengthen the development of medical devices. This is for sure also valid for medical devices assisting Covid-19 patients and to fight the Coronavirus globally.” - KIPA CEO Erik Krahbichler

 

KIPA (Krahbichler Intellectual Property Advisors) is an European IP boutique working with global clients. KIPA is specialized in medical technology (medtech) but handles any kind of IP cases. KIPA is experienced with prosecutions, litigations, oppositions as well as trademarks.

 

###

If you want more information about KIPA please contact KIPA at mail@kipa.se.

For press enquiries contact press@solitonsolutions.com

 

KIPA AB 

Drottninggatan 11

SE-252 21 Helsingborg

SWEDEN

VAT No. SE556713724401

http://Kipa.se

Media mentions:

https://www.intellectualpropertymagazine.com/people/kipa-calls-for-medical-device-applicants--1.htm

https://www.med-technews.com/news/ip-firm-shifts-focus-back-to-medical-devices/

The post Press Release: Patent Agency Kipa Shifts Focus Back to Medical Devices to Do Their Part in the COVID-19 Crisis appeared first on Soliton Solutions PR.

]]> https://www.solitonsolutions.com/2020/05/18/press-release-patent-agency-kipa-shifts-focus-back-to-medical-devices-to-do-their-part-in-the-covid-19-crisis/feed/ 0